Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference

3 years ago

-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels -Winter Camelina could expand acres available for…

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 30, 2022

3 years ago

HOUSTON, March 16, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced that it…

LIXTE Biotechnology Holdings, Inc. to Present at MedInvest Pharmaceutical and Biotechnology Investor Conference

3 years ago

PASADENA, CA, March 16, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically…

Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

3 years ago

Plans to present data at multiple scientific conferences in 2022 Expects to file INDs for leading CAR T ex vivo…

Radius Health Announces Leadership Appointments

3 years ago

BOSTON, March 16, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS), today announced appointments to…

Population Health Company AssureCare to Unveil Specialty Pharmacy Solution at HIMSS22

3 years ago

Visit booth #647 at HIMSS22 and see how AssureCare’s Specialty Pharmacy Solution is helping pharmacists deliver quality care and maximize…

RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality

3 years ago

Glen Rock, N.J., March 16, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in…

Sight Sciences Announces Appointment of Brenda Becker to Board of Directors

3 years ago

Legislative and health policy expert brings extensive private and public sector experienceMENLO PARK, Calif., March 16, 2022 (GLOBE NEWSWIRE) --…

BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain

3 years ago

VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF…

Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment

3 years ago

CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical…